olesoxime (TRO19622)

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Chemotherapy-Induced Peripheral NeuropathyRelapsing Remitting Multiple Sclerosis

Phase 1

Safety Study of Olesoxime in Patients With Stable Relapsing Remitting Multiple Sclerosis Treated With Interferon Beta.

CompletedNCT01808885

Hoffmann-La RocheRelapsing Remitting Multiple Sclerosis

Start: 2013-04-30End: 2014-01-31Updated: 2016-11-22

Phase 2

Effect of TRO19622 in the Treatment of Patients With Chemotherapy Induced Peripheral Neuropathy

CompletedNCT00876538

Hoffmann-La RocheChemotherapy-Induced Peripheral Neuropathy

Start: 2009-03-31End: 2010-09-30Updated: 2016-11-22